Toxicity and Quality of Life




Huang EH, Pollack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321PubMed


Huang GJ, Sadetsky N, Penson DF (2010) Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol 183:2206–2212PubMed


Iglicki F, Coffin B, Ille O et al (1996) Fecal incontinence after pelvic radiotherapy: evidences for a lumbosacral plexopathy. Report of a case. Dis Colon Rectum 39:465–467PubMed


Jenkinson C, Chandola T, Coulter A et al (2001) An assessment of the construct validity of the SF-12 summary scores across ethnic groups. J Publ Health Med 23:187–194


Jereczek-Fossa BA, Santoro L, Zerini D et al (2013) Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients. J Urol 189:2099–2103PubMed


Kaassis M, Oberti E, Burtin P et al (2000) Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy 32:673–676PubMed


Kennedy M, Bruninga K, Mutlu EA et al (2001) Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol 96:1080–1084PubMed


Kochhar R, Sriram PV, Sharma SC et al (1999) Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci 44:973–978PubMed


Kushwaha RS, Hayne D, Vaizey CJ et al (2003) Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer. Dis Colon Rectum 46:1182–1188PubMed


Lanciano RM, Martz K, Montana GS et al (1992) Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A Patterns Care Study Cancer 69:2124–2130


Lilleby W, Fossa SD, Waehre HR et al (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43:735–743PubMed


Lim LL, Fisher JD (1999) Use of the 12-item short-form (SF-12) health survey in an Australian heart and stroke population. Qual Life Res Int J Qual Life Aspects of Treat, Care Rehabil 8:1–8


Lips I, Dehnad H, Kruger AB et al (2007) Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy versus 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys 69:656–661PubMed


Lips IM, van Gils CH, van der Heide UA et al (2009) Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification. BJU Int 103:762–767PubMed


Litwin MS, Hays RD, Fink A et al (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129–135PubMed


Marchand V, Bourdin S, Charbonnel C et al (2010) No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 77:1053–1059PubMed


Michalski JM, Gay H, Jackson A et al (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76:S123–S129PubMedCentralPubMed


Munbodh R, Jackson A, Bauer J et al (2008) Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer. Med Phys 35:2137–2150PubMed


Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139–144PubMed


Pardo Y, Guedea F, Aguilo F et al (2010) Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 28:4687–4696PubMed


Peeters ST, Heemsbergen WD, Koper PC et al (2006a) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990–1996PubMed


Peeters ST, Hoogeman MS, Heemsbergen WD et al (2006b) Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66:11–19PubMed

Oct 1, 2016 | Posted by in GENERAL RADIOLOGY | Comments Off on Toxicity and Quality of Life

Full access? Get Clinical Tree

Get Clinical Tree app for offline access